Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 26;289(52):35724-30.
doi: 10.1074/jbc.C114.602698. Epub 2014 Nov 19.

Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA)

Affiliations

Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA)

Satoshi Ito et al. J Biol Chem. .

Abstract

Human N-acetyltransferase 10 (NAT10) is known to be a lysine acetyltransferase that targets microtubules and histones and plays an important role in cell division. NAT10 is highly expressed in malignant tumors, and is also a promising target for therapies against laminopathies and premature aging. Here we report that NAT10 is an ATP-dependent RNA acetyltransferase responsible for formation of N(4)-acetylcytidine (ac(4)C) at position 1842 in the terminal helix of mammalian 18 S rRNA. RNAi-mediated knockdown of NAT10 resulted in growth retardation of human cells, and this was accompanied by high-level accumulation of the 30 S precursor of 18 S rRNA, suggesting that ac(4)C1842 formation catalyzed by NAT10 is involved in rRNA processing and ribosome biogenesis.

Keywords: Acetyl Coenzyme A (Acetyl-CoA); Acetyltransferase; RNA Modification; Ribosomal RNA Processing (rRNA Processing); Ribosome Assembly.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
N4-Acetylcytidine is present at position 1842 in human 18 S rRNA. A, the secondary structure of human 18 S rRNA (left) with a detailed description of helix 45 and the surrounding region (right box), with modified nucleosides: ac4C at position 1842, N6,N6-dimethyladenosine (m62A) at positions 1850 and 1851, 2′-O-methylcytidine (Cm) at position 1703, and N6-methyladenosine (m6A) at position 1832. The in vitro transcribed RNA segment (G1820–A1869) used for ac4C formation is shown in blue. The ac4C-containing hexamer fragment generated by RNase T1 digestion is shown in green. Watson-Crick base pairs and wobble pairs are shown as bars and dots, respectively. B, capillary LC/ESI-MS analysis of fragments of RNase T1-digested 18 S rRNA from HEK293 cells. The upper panel shows the base-peak chromatogram (BPC), and the lower panel shows the mass chromatogram of the doubly charged ion of the ac4C-containing hexamer fragment (UUUCac4CGp, m/z 965.6). C, CID spectrum of the ac4C-containing hexamer fragment. The doubly charged ion (m/z 965.6) was used as the parent for CID. The sequence was confirmed by assignment of the product ions. The nomenclature for product ions is according to a previous study (24).
FIGURE 2.
FIGURE 2.
NAT10 is an ATP-dependent RNA acetyltransferase involved in 18 S rRNA processing. A, Western blotting (WB) of endogenous NAT10 to estimate the knockdown efficiency of three siRNAs against NAT10 (siNAT10) and an siRNA against luciferase (siLUC), used as a negative control. Coomassie Brilliant Blue (CBB) staining of each sample is shown as a loading control (LC). Knockdown efficiencies of the three siRNAs, estimated from the levels of NAT10 mRNA (normalized by ACTB mRNA), were 10.6% (siNAT10a), 12.5% (siNAT10b), and 3.2% (siNAT10c), respectively. B, growth curves of HeLa cells treated with siRNAs against NAT10 (green and blue lines for siNAT10b and siNAT10c, respectively) or luciferase (black line for siLUC). Each plot is the average of three independent cultures (bars, ±S.D.). C, flow cytometry of HeLa cells treated with siRNAs against NAT10 (right panel) or luciferase (left panel), stained with annexin V-FITC (x-axis) and propidium iodide (y-axis). D, capillary LC/ESI-MS analyses of fragments of RNase T1-digested 18 S rRNAs from the HEK293 cells treated with siNAT10a against NAT10 (lower panels) or luciferase (upper panels). Mass chromatograms of the doubly charged ions of the ac4C-containing hexamers (UUUCac4CGp, m/z 965.6) and control fragments (AUUAmAGp, m/z 987.1) are shown in the left and right panels, respectively. The intensities of the ac4C-containing hexamers in the mass chromatograms were normalized to those of the control fragments. E, schematic depiction of the rRNA processing pathways in humans. In the canonical pathway, 47 S pre-rRNA is processed by endonucleolytic cleavages at sites 01 and 02 to yield 45 S pre-rRNA, which is then processed into 30 S pre-rRNA by cleavage at site 2 in ITS1. Precursors for large subunit formation are not shown. 30 S pre-rRNA is further processed into 21 S pre-rRNA by removal of the 5′-ETS. Finally, 18 S rRNA is produced by removal of ITS1. Complementary regions of probes a, b, and c are indicated. The position of ac4C1842 is indicated by the circle flag. Processing sites in pre-rRNA are indicated. F, accumulation of 30 S pre-rRNA and disappearance of 21 S pre-rRNA upon NAT10 depletion by siNAT10b. Precursors of 18 S rRNA were detected by Northern blotting. Steady-state levels of 28 S and 18 S rRNAs were visualized by EtBr staining, as a loading control. The 45 S and 30 S pre-rRNAs were detected by all three probes, whereas 21 S pre-rRNA was detected only by probes b and c. G, sucrose density gradient centrifugation profiling of ribosomal subunits in HeLa cells treated with siRNAs for luciferase (siLUC, black line) and NAT10 (siNAT10c, blue line). Absorbance at 254 nm was monitored from the top to bottom of the centrifugation tubes. H, in vitro reconstitution of ac4C1842 in the 50-mer RNA segment, including helix 45 (Fig. 1A) in the presence or absence of recombinant Nat10, ATP, and acetyl-CoA. The left and right panels show mass chromatograms of the hexamer fragments carrying ac4C1842 (UUUCac4CGp, m/z 965.6) and C1842 (UUUCCGp, m/z 944.6), respectively. I, confirmation of the reconstituted ac4C1842 in the 50-mer RNA fragment. A CID spectrum of the ac4C-containing hexamer fragment digested with RNase T1 is shown. The doubly charged ion (m/z 965.6) was used as the parent for CID. The sequence was confirmed by assignment of the product ions. Nomenclature for product ions is as suggested in a previous study (24).

References

    1. Mullineux S. T., Lafontaine D. L. (2012) Mapping the cleavage sites on mammalian pre-rRNAs: where do we stand? Biochimie 94, 1521–1532 - PubMed
    1. Sondalle S. B., Baserga S. J. (2014) Human diseases of the SSU processome. Biochim. Biophys. Acta 1842, 758–764 - PMC - PubMed
    1. McCann K. L., Baserga S. J. (2013) Mysterious ribosomopathies. Science 341, 849–850 - PMC - PubMed
    1. Piekna-Przybylska D., Decatur W. A., Fournier M. J. (2008) The 3D rRNA modification maps database: with interactive tools for ribosome analysis. Nucleic Acids Res. 36, D178–D183 - PMC - PubMed
    1. Reichow S. L., Hamma T., Ferré-D'Amaré A. R., Varani G. (2007) The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res. 35, 1452–1464 - PMC - PubMed

Publication types

Substances